期刊文献+

骨桥蛋白与肿瘤侵袭转移关系的研究进展 被引量:11

Correlation between osteopontin and malignant infiltration and metastasis,a brief update
下载PDF
导出
摘要 骨桥蛋白(Osteopontin,OPN)是一种磷酸化蛋白质,在人体组织中广泛分布,具有多种功能。OPN不与在组织发育过程,而且与许多疾病,如炎症、免疫反应、血管重建等有关。OPN与肿瘤转移的关系日益引起人们的关注,已被广泛公认为是肿瘤转移相关基因或转移基因。针对肿瘤转移基因OPN及其受体的干预,可能成为防治肿瘤转移的潜在靶点。同时,OPN也可能是肿瘤远处转移和预后的预测分子。本文就骨桥蛋白与恶性肿瘤侵袭转移之间的研究进展进行综述。 Osteopontin belongs to the family of phosphorylated protein.It distributed in various human tissues and was known to have multiple functions.OPN not only reacts during tissue development,but also related with many diseases,such as inflammation,immune response,and revascularization.Recently,much attention was paid to the role of OPN on tumor metastasis.It was generally accepted as a metastasis-related gene or a metastic gene.The intervention in the metastatic gene OPN or its receptors were considered as potent therapeutic targets for tumor metastasis.Meanwhile,OPN could serve as a predicter for distal metastasis as well as a prognosis factor for malignant tumors.Here we reviewed the up-to-date investigations on the role of OPN in malignant infiltration and metastasis.
机构地区 辽宁省肿瘤医院
出处 《现代肿瘤医学》 CAS 2012年第2期419-422,共4页 Journal of Modern Oncology
基金 辽宁省科学技术研究基金项目(编号:2010225015)
关键词 骨桥蛋白 恶性肿瘤 转移 侵袭 osteopontin malignancies metastasis infiltration
  • 相关文献

参考文献26

  • 1Oldberg A,Franzen A,Heinegard D.Cloning and sequence analysis of rat bone sialoprotein(osteopontin)cDNA reveals an Arg-Gly-Asp cell-binding sequence[J].Proc Natl Acad Sci USA,1986,83(23):8819-8823. 被引量:1
  • 2Saitoh Y,Kuratsu J,Takeshima H,et al.Expression of osteopontin in human glioma.Its correlation with the malignancy[J].Lab Invest,1995,72(1):55-63. 被引量:1
  • 3Zohar R,Suzuki N,Suzuki K,et al.Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration[J].J Cell Physiol,2000,184(1):118-130. 被引量:1
  • 4Gao C,Gou H,Downey L,et al.Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells[J].Carcinogenesis,2003,24(12):1871-1878. 被引量:1
  • 5Liaw L,Birk DE,Ballas CB,et al.Altered wound healing in mice lacking a functional osteopontin gene(spp1)[J].J Clin Invest,1998,101(7):1468-1478. 被引量:1
  • 6Senger DR,Ledbetter SR,Claffey KP,et al.Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin,osteopontin,and thrombin[J].Am J Pathol,1996,149(1):293-305. 被引量:1
  • 7Denhardt DT,Noda M,O'Regan AW,et al.Osteopontin as a means to cope with environmental insults:regulation of inflammation,tissue remodeling,and cell survival[J].J Clin Invest,2001,107(9):1055-1061. 被引量:1
  • 8Michael E,Ilana A,Hua Q,et al.Inhibition of bladder carcinoma angiogenesis,stromal support,and tumor growth by halofuginone[J].Cancer Res,1999,59:4111-4118. 被引量:1
  • 9Uemura T,Liu YK,Kuboki Y.Preliminary communication.mRNA expression of MT1-MMP,MMP-9,cathepsin K,and TRAP in highly enriched osteoclasts cultured on several matrix proteins and ivory surfaces[J].Biosci Biotechnol Biochem,2000,64(8):1771-1773. 被引量:1
  • 10Tuck AB,Elliott BE,Hota C,et al.Osteopontin-induced,integrin-dependent migration of human mammary epceptor(Met)[J].J Cell Biochem,2000,78(3):465-475. 被引量:1

二级参考文献23

  • 1Rosen G. Preoperative (neoadjuvant) chemotherapy for osteogenic scarcoma: A ten years experience[J]. Orthop,1985, 8(5): 659-664. 被引量:1
  • 2Longhi A, Errani C, De Paolis M, et al. Primary bone osteosarcoma in the pediatric age: state of the art [J]. Cancer Treat Rev, 2006,32 (6): 423-436. 被引量:1
  • 3Takeshita H, Kusuzaki K, Ashihara T, et al. Intrinsic resistance to chemotherapeutic agents in routine osteosarcoma cells [J]. J Bone Joint Surg Am, 2000, 82-A(7):963-969. 被引量:1
  • 4Fuchs N, Bielack SS, Epler D, et al. Long-term results of the co-opera- tive German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive mutidrug chemotherapy and surgery for osteosarcoma of the limbs[J]. Ann Oncol, 1998, 9 (3): 893-899. 被引量:1
  • 5Ferrari S, Smeland S, Mercuri M, et al. Neoadjuvant chemotherapy with high-dose ifosfarnide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian sarcoma groups [J]. JClin Oncol, 2005, 23 (34):8845-8852. 被引量:1
  • 6Bacci G, Fomi C, Ferrair S, et al. Neoadjuvant chemotherapy for osteosarcoma of extremity: Intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome [J]. J Pediatr Hematol Oncol, 2003, 25 (11):845-853. 被引量:1
  • 7Patel SJ, Lynch JW, Johnson T, et al. Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults[J]. Am J Clin Oncol, 2002, 25 (5):489-495. 被引量:1
  • 8Bookman MA, Darcy KM, Clarke-Pearson D, et al. Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the gynecologic Oncology Group[J]. JClin Oncol, 2003, 21 (2):283-290. 被引量:1
  • 9Cn'aessmann M, Berg B, Fuchs B, et al. Chemotherapy resistance of mouse WAP-SVT/t breast cancer cells is mediated by osteoponiin, inhibiting apoptosis downstream of caspase-3 [J]. Oneogene, 2007, 26 (20): 2840-2850. 被引量:1
  • 10Kon S, Maeda M, Segawa T, et al. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms [J]. J Cell Biochem,2000, 77(3):487-498. 被引量:1

共引文献3

同被引文献94

引证文献11

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部